Recommended for: patients on tirzepatide seeking maximum energy support, patients with documented methylation challenges (MTHFR variants), patients prioritizing cognitive clarity during weight loss
Is NAD+ Right for You
[36] This randomized, double-blind, placebo-controlled trial found that 200mg of ButyraGen daily led to: Statistically significant reductions in reported belly pain across the study population 20% improvement in women, with even greater benefits in postmenopausal women Improved digestive-related quality of life scores Improvements in both upper and lower digestive comfort Excellent safety profile with no adverse events These studies are explained in greater detail in our article titled " ButyraGen: Next-Generation Prebiotic From NutriScience Innovations That Generates Butyrate Directly " , and demonstrate that ButyraGen provides measurable support for digestive wellness in real-world settings
For our patients who travel frequently (perhaps for business in Lone Tree or Centennial ), struggle with injections, or simply prefer a daily routine, this offers much greater flexibility
So I decided to give it a real, no-BS trial
Oncotarget 8, 102989103003
